Gabelli Merchant Partners PLC · LSE:GMP
Gabelli Merchant Partners — Gabelli Merger Plus+ Trust — Fact Sheet (September 2018)
5 slides from Gabelli Merchant Partners's fact sheet, September 2018
Slide 1: Quarter Ended September 30, 2018 - Profile and Performance
G IM Pp Quarter Ended September 30, 2018 THE GABELLI GABELLI MERGER PLUS* TRUST LON: GMP SEDOL/ISIN: BD8P074 / GBOOBD8P0741 PROFILE THIRD QUARTER 2018 REPORT The Gabelli Merger Plus” Trust’s primary investment objective is to seek to Total Net Assets: $100.9 Million generate total return, consisting
Slide 2: Sector Exposure, Selected Holdings and Commentary
SECTOR EXPOSURE” SELECTED HOLDINGS mGMP mRussell 3000 m=S&P500 o Avista Corp o =CAInc o Express Scripts Inc Communication Services Consumer Discretionary co Frutarom Industries Consumer Staples o Gemalto Energy o Kix Inc Financials o Orbotech Ltd o Shire Plc Healthcare ; ; o Tribune Media Industrial
Slide 3: Commentary on merger momentum and recent performance
The United States has been central to merger momentum globally. The U.S. tax reforms continue to support event activity as the repatriation of overseas cash bolsters balance sheets and spurs deal activity. Progressive initiatives for deregulation are expected to alleviate burdens and hurdles for dea
Slide 4: Selected Current Deals
Abaxis, Inc. (ABAX-$82.80-NASDAQ) agreed to be acquired by Zoetis (ZTS-$83.70-NYSE). Abaxis manufactures portable blood analysis systems used in both human and veterinary care. Under terms of the agreement Abaxis shareholders received $83.00 cash per share, valuing the transaction at approximately $
Slide 5: Disclosure
DISCLOSURE ' Portfolio composition is reflective of the portfolio as of the date of this report, but is not necessarily indicative of the composition of the portfolio in the future which may be significantly different than that show here. The classifications of market capitalisation, sector, and geo
Gabelli Merger Plus+ Trust — Fact Sheet (September 2018) on 6ix